{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T07:49:24Z","timestamp":1791532164806,"version":"4.3.4"},"reference-count":38,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,10,9]],"date-time":"2027-10-09T00:00:00Z","timestamp":1823040000000},"content-version":"am","delay-in-days":373,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100031022","name":"Center for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031022","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jtct.2026.05.034","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T23:56:47Z","timestamp":1779926207000},"page":"1246.e1-1246.e10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Desmosine as a Novel Biomarker Candidate for Pulmonary and Cutaneous Chronic Graft-Versus-Host Disease"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5638-8962","authenticated-orcid":false,"given":"Aaron T.","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7919-0211","authenticated-orcid":false,"given":"Filip","family":"Pirsl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackie","family":"Parkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4388-4825","authenticated-orcid":false,"given":"Alain","family":"Mina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rania","family":"Hishmeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noa G.","family":"Holtzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6672-4592","authenticated-orcid":false,"given":"Eduard","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9111-9354","authenticated-orcid":false,"given":"Steven Z.","family":"Pavletic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9268-9655","authenticated-orcid":false,"given":"Najla","family":"El Jurdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"26","key":"10.1016\/j.jtct.2026.05.034_bib0001","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1056\/NEJMra1703472","article-title":"Pathophysiology of chronic graft-versus-host disease and therapeutic targets","volume":"377","author":"Zeiser","year":"2017","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1016\/j.jtct.2026.05.034_bib0002","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1182\/blood.2023022735","article-title":"Chronic graft-versus-host disease: unresolved complication or ancient history?","volume":"144","author":"Pidala","year":"2024","journal-title":"Blood"},{"issue":"22","key":"10.1016\/j.jtct.2026.05.034_bib0003","doi-asserted-by":"crossref","first-page":"5829","DOI":"10.1182\/bloodadvances.2024012722","article-title":"Decreasing chronic graft-versus-host disease rates in all populations","volume":"8","author":"Carpenter","year":"2024","journal-title":"Blood Adv"},{"issue":"3","key":"10.1016\/j.jtct.2026.05.034_bib0004","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National Institutes of Health Consensus Development Project on Criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 Diagnosis and Staging Working Group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplantat"},{"issue":"9","key":"10.1016\/j.jtct.2026.05.034_bib0005","doi-asserted-by":"crossref","first-page":"e446","DOI":"10.1097\/TP.0000000000005345","article-title":"Chronic graft-versus-host disease, part 2: clinical success and roadmap to the future","volume":"109","author":"El Jurdi","year":"2025","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.jtct.2026.05.034_bib0006","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1001\/jama.2009.1018","article-title":"Bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation","volume":"302","author":"Williams","year":"2009","journal-title":"JAMA"},{"issue":"25","key":"10.1016\/j.jtct.2026.05.034_bib0007","doi-asserted-by":"crossref","first-page":"5098","DOI":"10.1182\/blood-2012-10-464198","article-title":"Incidence, risk factors, and outcomes of sclerosis in patients with chronic graft-versus-host disease","volume":"121","author":"Inamoto","year":"2013","journal-title":"Blood"},{"issue":"1 Suppl","key":"10.1016\/j.jtct.2026.05.034_bib0008","doi-asserted-by":"crossref","first-page":"S106","DOI":"10.1016\/j.bbmt.2009.11.002","article-title":"Bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation-an increasingly recognized manifestation of chronic graft-versus-host disease","volume":"16","author":"Chien","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"10.1016\/j.jtct.2026.05.034_bib0009","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1183\/09031936.00107514","article-title":"An international ISHLT\/ATS\/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndrome","volume":"44","author":"Meyer","year":"2014","journal-title":"Eur Respiratory J"},{"issue":"15","key":"10.1016\/j.jtct.2026.05.034_bib0010","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1182\/blood-2011-04-350249","article-title":"Sclerotic-type chronic GVHD of the skin: clinical risk factors, laboratory markers, and burden of disease","volume":"118","author":"Martires","year":"2011","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.jtct.2026.05.034_bib0011","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.bbmt.2011.04.002","article-title":"A multicenter pilot evaluation of the National Institutes of Health chronic graft-versus-host disease (cGVHD) therapeutic response measures: feasibility, interrater reliability, and minimum detectable change","volume":"17","author":"Mitchell","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"10.1016\/j.jtct.2026.05.034_bib0012","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1001\/jamadermatol.2018.5459","article-title":"Interrater reliability of clinical grading measures for cutaneous chronic graft-vs-host disease","volume":"155","author":"Cardones","year":"2019","journal-title":"JAMA Dermatol"},{"issue":"5","key":"10.1016\/j.jtct.2026.05.034_bib0013","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.bbmt.2015.01.003","article-title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2014 Biomarker Working Group Report","volume":"21","author":"Paczesny","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jtct.2026.05.034_bib0014","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/cjp2.58","article-title":"A combined biomarker and clinical panel for chronic graft versus host disease diagnosis","volume":"3","author":"Pidala","year":"2017","journal-title":"J Pathol Clin Res"},{"issue":"5","key":"10.1016\/j.jtct.2026.05.034_bib0015","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1183\/09031936.00174807","article-title":"Desmosine as a biomarker of elastin degradation in COPD: current status and future directions","volume":"32","author":"Luisetti","year":"2008","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.jtct.2026.05.034_bib0016","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S1357-2725(02)00015-8","article-title":"Urinary desmosine excretion is inversely correlated with the extent of emphysema in patients with chronic obstructive pulmonary disease","volume":"34","author":"Cocci","year":"2002","journal-title":"Int J Biochem Cell Biol"},{"issue":"Supplement 1","key":"10.1016\/j.jtct.2026.05.034_bib0017","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1182\/blood-2021-151324","article-title":"Effects of alvelestat, an oral neutrophil elastase inhibitor, on elevated elastase and collagen turnover biomarkers in patients with bronchiolitis obliterans syndrome after hematopoietic cell transplantation","volume":"138","author":"Im","year":"2021","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.jtct.2026.05.034_bib0018","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1002\/art.38697","article-title":"Prevalence of isolated joint involvement in chronic graft-versus-host disease: comment on the article by Inamoto et al","volume":"66","author":"Kuzmina","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"10.1016\/j.jtct.2026.05.034_bib0019","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1136\/thoraxjnl-2011-200279","article-title":"Clinical validity of plasma and urinary desmosine as biomarkers for chronic obstructive pulmonary disease","volume":"67","author":"Huang","year":"2012","journal-title":"Thorax"},{"issue":"Supplement_2","key":"10.1016\/j.jtct.2026.05.034_bib0020","doi-asserted-by":"crossref","DOI":"10.1093\/ehjci\/ehaa946.1351","article-title":"Plasma desmosine, a biomarker of elastin degradation, predicts outcomes in coronary artery disease","volume":"41","author":"Iskandar","year":"2020","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.jtct.2026.05.034_bib0021","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/leu.2011.254","article-title":"Clinical laboratory markers of inflammation as determinants of chronic graft-versus-host disease activity and NIH global severity","volume":"26","author":"Grkovic","year":"2012","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.jtct.2026.05.034_bib0022","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.3324\/haematol.2011.049841","article-title":"The global severity of chronic graft-versus-host disease, determined by National Institutes of Health consensus criteria, is associated with overall survival and non-relapse mortality","volume":"96","author":"Pidala","year":"2011","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.jtct.2026.05.034_bib0023","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3324\/haematol.2023.283646","article-title":"Red cell distribution width as a new prognostic biomarker in refractory chronic graft-versus-host disease","volume":"109","author":"Schulz","year":"2024","journal-title":"Haematologica"},{"issue":"8","key":"10.1016\/j.jtct.2026.05.034_bib0024","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1136\/thx.41.8.577","article-title":"Elastin and the lung","volume":"41","author":"Starcher","year":"1986","journal-title":"Thorax"},{"key":"10.1016\/j.jtct.2026.05.034_bib0025","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.matbio.2018.01.005","article-title":"Elastin in lung development and disease pathogenesis","volume":"73","author":"Mecham","year":"2018","journal-title":"Matrix Biol"},{"issue":"4","key":"10.1016\/j.jtct.2026.05.034_bib0026","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3109\/15412555.2012.697753","article-title":"Elastin degradation: an effective biomarker in COPD","volume":"9","author":"Turino","year":"2012","journal-title":"Copd"},{"issue":"6","key":"10.1016\/j.jtct.2026.05.034_bib0027","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1034\/j.1399-3003.2000.01511.x","article-title":"MEKC of desmosine and isodesmosine in urine of chronic destructive lung disease patients","volume":"15","author":"Viglio","year":"2000","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.jtct.2026.05.034_bib0028","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1378\/chest.06-2251","article-title":"Measurements of desmosine and isodesmosine by mass spectrometry in COPD","volume":"131","author":"Ma","year":"2007","journal-title":"Chest"},{"issue":"17","key":"10.1016\/j.jtct.2026.05.034_bib0029","doi-asserted-by":"crossref","first-page":"4984","DOI":"10.1182\/bloodadvances.2022008201","article-title":"Graft-versus-host disease may cause pulmonary restriction, but not all restriction is graft-versus-host disease","volume":"6","author":"Sheshadri","year":"2022","journal-title":"Blood Adv"},{"issue":"10","key":"10.1016\/j.jtct.2026.05.034_bib0030","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1038\/bmt.2011.35","article-title":"Diagnosis and treatment of pulmonary chronic GVHD: report from the consensus conference on clinical practice in chronic GVHD","volume":"46","author":"Hildebrandt","year":"2011","journal-title":"Bone Marrow Transplantat"},{"issue":"5","key":"10.1016\/j.jtct.2026.05.034_bib0031","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/his.13697","article-title":"Lung histopathology of non-infectious pulmonary complications after allogeneic haematopoietic stem cell transplantation","volume":"73","author":"Meignin","year":"2018","journal-title":"Histopathology"},{"issue":"3","key":"10.1016\/j.jtct.2026.05.034_bib0032","doi-asserted-by":"crossref","first-page":"ojab019","DOI":"10.1093\/asjof\/ojab019","article-title":"Clinical relevance of elastin in the structure and function of skin","volume":"3","author":"Baumann","year":"2021","journal-title":"Aesthet Surg J Open Forum"},{"issue":"4","key":"10.1016\/j.jtct.2026.05.034_bib0033","first-page":"373","article-title":"Dermal elastin and collagen in systemic sclerosis. Effect of D-penicillamine treatment","volume":"7","author":"Pasquali Ronchetti","year":"1989","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"10.1016\/j.jtct.2026.05.034_bib0034","first-page":"791","article-title":"Extracellular microfibrils are increased in localized and systemic scleroderma skin","volume":"64","author":"Fleischmajer","year":"1991","journal-title":"Lab Invest"},{"issue":"2","key":"10.1016\/j.jtct.2026.05.034_bib0035","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.bbmt.2016.09.023","article-title":"The biology of chronic graft-versus-host disease: a task force report from the National Institutes of Health Consensus Development Project on Criteria for clinical trials in chronic graft-versus-host disease","volume":"23","author":"Cooke","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jtct.2026.05.034_bib0036","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41514-024-00143-7","article-title":"Accelerated elastin degradation by age-disease interaction: a common feature in age-related diseases","volume":"10","author":"Shek","year":"2024","journal-title":"NPJ Aging"},{"issue":"2","key":"10.1016\/j.jtct.2026.05.034_bib0037","doi-asserted-by":"crossref","first-page":"H189","DOI":"10.1152\/ajpheart.00087.2018","article-title":"Elastin, arterial mechanics, and cardiovascular disease","volume":"315","author":"Cocciolone","year":"2018","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"21","key":"10.1016\/j.jtct.2026.05.034_bib0038","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/j.jchromb.2011.05.011","article-title":"Quantitation of desmosine and isodesmosine in urine, plasma, and sputum by LC-MS\/MS as biomarkers for elastin degradation","volume":"879","author":"Ma","year":"2011","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726004276?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726004276?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T06:58:15Z","timestamp":1791529095000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636726004276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2666636726004276"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2026.05.034","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Desmosine as a Novel Biomarker Candidate for Pulmonary and Cutaneous Chronic Graft-Versus-Host Disease","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2026.05.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of American Society for Transplantation and Cellular Therapy.","name":"copyright","label":"Copyright"}]}}